Praxis Medical Insights

Est. 2024 • Clinical Guidelines Distilled

Made possible by volunteer editors from the University of Calgary & University of Alberta

Last Updated: 9/22/2025

Treatment of Scalp Seborrheic Dermatitis and Psoriasis with Tenderness

Initial Treatment Phase

  • The American Academy of Dermatology recommends initiating combination therapy with a moderate-to-high potency topical corticosteroid applied twice weekly alternating with ketoconazole 2% shampoo twice weekly for 4 weeks, followed by maintenance with ketoconazole once weekly 1
  • Apply emollients 1-3 times daily to reduce scaling and maintain skin barrier function, as suggested by the Praxis Medical Insights 2
  • Consider adding calcipotriol (vitamin D analog) on non-corticosteroid days if psoriatic plaques predominate, according to the Journal of the American Academy of Dermatology and Praxis Medical Insights 3, 1

Special Considerations for Scalp Tenderness

  • The Journal of the American Academy of Dermatology suggests that scalp tenderness requires prompt anti-inflammatory treatment with moderate-to-high potency corticosteroids, which provide rapid symptom relief within 3-4 weeks 4
  • Avoid using systemic corticosteroids, as they can precipitate severe psoriasis flares upon discontinuation, according to Praxis Medical Insights 1
  • Avoid medications that worsen psoriasis, including lithium, chloroquine, beta-blockers, and NSAIDs, as recommended by the BMJ and Praxis Medical Insights 5, 6, 1

Monitoring Requirements

  • Regular clinical review every 4 weeks during active treatment is recommended by the BMJ and Praxis Medical Insights 5, 1
  • No unsupervised repeat prescriptions of corticosteroids, and a maximum of 100g of moderate-potency corticosteroid per month, as suggested by the BMJ 5
  • Plan annual periods using alternative non-corticosteroid treatments, according to the BMJ and Praxis Medical Insights 5, 1

When to Escalate Care

  • Refer to dermatology if scalp tenderness persists despite adequate anti-inflammatory treatment, as recommended by the Journal of the American Academy of Dermatology 4
  • Refer to dermatology if signs of erythrodermic or pustular psoriasis develop, according to the Journal of the American Academy of Dermatology and Praxis Medical Insights 7, 6

Treatment of Scalp Seborrheic Dermatitis and Psoriasis with Tenderness

Initial Treatment Phase

  • The American Academy of Dermatology recommends clobetasol propionate 0.05% shampoo applied twice weekly, leaving on scalp for 5-10 minutes before rinsing, as part of the initial treatment phase for scalp seborrheic dermatitis and psoriasis, to provide rapid symptom relief within 3-4 weeks 8
  • The use of clobetasol propionate 0.05% shampoo as part of a combination regimen demonstrates significantly greater efficacy than either agent alone, with sustained effect during maintenance and superior reduction in erythema, scaling, and pruritus, according to the American Academy of Dermatology 8

Maintenance Phase

  • The American Academy of Dermatology suggests discontinuing clobetasol after 4 weeks maximum to avoid skin atrophy, striae, telangiectasia, and HPA axis suppression, and transitioning to ketoconazole 2% shampoo once weekly to sustain remission and prevent relapse 8

Critical Monitoring Requirements

  • The American Academy of Dermatology recommends reviewing patients clinically every 4 weeks during active treatment to assess response and monitor for adverse effects, such as skin atrophy, particularly on face and intertriginous areas if disease extends beyond scalp 8

Common Pitfalls to Avoid

  • The American Academy of Dermatology advises against abrupt corticosteroid withdrawal, recommending tapering frequency gradually after clinical improvement to prevent rebound flare, with a strength of evidence supported by studies from 2009 and 2021 8, 9

Alternative Second-Line Options

  • The American Academy of Dermatology suggests intralesional triamcinolone acetonide (up to 20 mg/mL every 3-4 weeks) as a second-line option for localized non-responding thick plaques, and calcineurin inhibitors (tacrolimus, pimecrolimus) as steroid-sparing agents for prolonged use, particularly useful for facial/intertriginous extension 8

REFERENCES

1

Management of Psoriasis [LINK]

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

2

Treatment of Psoriasis Affecting the Ears [LINK]

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

6

Psoriasis Characterization and Treatment [LINK]

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025